Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2015

Cerebral Protection Devices Are Still Meaningful and Necessary

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

CTA Is the Gold Standard for TAVR Valve Sizing

Presenter: Jonathon A. Leipsic

June 05, 2015

Presentation TVT 2015

Angiography Is Adequate for Valve Sizing Decisions and PVR Assessment

Presenter: Albert Markus Kasel

June 05, 2015

Presentation TVT 2015

PVR After TAVR Controversies: Clinical Relevance, Diagnostic Considerations, and Postdilation Strategies

Presenter: Susheel K. Kodali

June 05, 2015

Presentation TVT 2015

Defending Selective TEE: The Oh My God Scenarios

Presenter: Rebecca T. Hahn

June 05, 2015

Presentation TVT 2015

The Minimalist Approach = My Standard Practice

Presenter: Ganesh Manoharan

June 05, 2015

Presentation TVT 2015

Strokes After TAVR: Reasons for Declining Frequency

Presenter: Samir R. Kapadia

June 05, 2015

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Advertisement

What Do I Do With a Patient With Cryptogenic Stroke?

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Cerebral Protection Devices Are Still Meaningful and Necessary

CTA Is the Gold Standard for TAVR Valve Sizing

Angiography Is Adequate for Valve Sizing Decisions and PVR Assessment

PVR After TAVR Controversies: Clinical Relevance, Diagnostic Considerations, and Postdilation Strategies

Defending Selective TEE: The Oh My God Scenarios

The Minimalist Approach = My Standard Practice

Strokes After TAVR: Reasons for Declining Frequency

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Has Stroke Frequency Declined After TAVR?

Perspectives from the US CoreValve Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content